Skip to main content
SpringerLink
Log in

Combined Thrombolysis with Abciximab Favourably Influences Platelet-Leukocyte Interactions and Platelet Activation in Acute Myocardial Infarction

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background: In patients with acute myocardial infarction (AMI), activated platelets and altered haemostatic/fibrinolytic systems with and without thrombolytic therapy are known. Platelets thereby interact with neutrophils, stimulated endothelial cells and with monocytes leading to adverse effects on further myocardial damage. Thrombolysis in these patients is still hampered by procoagulant effects favoring early reocclusion. The additional treatment with a GPIIb/IIIa antagonist aimed to minimize early reocclusion thus improving the present therapeutic regimen.

Methods: In 38 patients with AMI, we investigated the effects of a thrombolytic regimen with half reteplase (r-PA) dose plus abciximab vs. full dose r-PA on membrane-bound adhesion molecules (CD41, CD42b, CD40, CD40L) expressed on platelets, neutrophils and monocytes as well as on soluble platelet-selectin as interaction and activation markers of these cells.

Results: The combination group had significantly (p < 0.05) lower sP-selectin levels over 48 h vs. the group treated with full dose r-PA. After 3 h, the percentage of CD41 and CD42b positive monocytes and granulocytes as well as the percentage of CD40 positive granulocytes and the percentage of CD40L positive monocytes markedly (p < 0.01, p < 0.05) decreased in the combination group vs. data at admission compared with the r-PA group indicating less leukocyte-patelet adhesion.

Conclusions: The thrombolytic regimen with half dose r-PA and abciximab had a benefical influence on platelet activation and induced a more marked decrease of platelet-monocyte, and in part, platelet-granulocyte aggregates compared with the r-PA regimen. This could contribute to a probably lesser monocyte activation state with favourable effects on monocyte-endothelial adhesion and a consecutively possible influence of myocardial damage, a reduction of the additionally acute local inflammatory processes and a reduction of adherence of platelet-granulocyte aggregates to subendothelium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo. after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142–150.

    PubMed  Google Scholar 

  2. Hoffmeister HM, Szabo S, Kastner C, et al. Thrombolytic therapy in acute myocardial infarction: Comparison of procoagulant effects of streptokinase and alteplase regimen with focus on the kallikrein system and plasmin. Circulation. 1998;98:2527–2533.

    PubMed  Google Scholar 

  3. Szabo S, Letsch R, Ehlers R, et al. Absence of paradoxical thrombin activation by fibrin- specific thrombolytics in acute myocardial infarction. Comparison of single bolus tenecteplase and front-loaded alteplase. Thromb Res. 2002;106:113–119.

    Article  PubMed  Google Scholar 

  4. Bazzoni G, Dejana E, Del Maschio A. Platelet-neutrophil interactions: Possible relevance in thepathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491–499.

    PubMed  Google Scholar 

  5. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo. by P.-selectin on adherent platelets. Nature. 1992;359:848–851.

    Article  PubMed  Google Scholar 

  6. Ruf A, Schlenk RF, Maras A, Morgenstern E, Patscheke H. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood. 1992;80:1238–1246.

    PubMed  Google Scholar 

  7. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost. 1993;70:514–521.

    PubMed  Google Scholar 

  8. Ruf A, Patscheke H. Platelet-induced neutrophil activation: Platelet-expressed fibrinogen induced the oxidative burst in neutrophils by an interaction with CD11c/CD18. Br J Haematol. 1995;90:791–796.

    PubMed  Google Scholar 

  9. Boukerche H, Ruchaud-Sparagano MH, Rouen C, Brochier J, Kaplan C, McGregor JL. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P.-selectin, CD 62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol. 1996;92:442–451.

    Article  PubMed  Google Scholar 

  10. Topol EJ, Califf RM, Van de Werf F, Willerson JT and the GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy of combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. The Lancet. 2001;357:1905–1910.

    Article  Google Scholar 

  11. Moliterno DJ, Califf RM, Aguirre FV, et al., for the EPIC Study Investigators. Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (The EPIC Trial). Am J Cardiol. 1995;75:559–562.

    Article  PubMed  Google Scholar 

  12. Stenberg PE, McEver RP, Shuman MA et al. A platelet alpha granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880–886.

    Article  PubMed  Google Scholar 

  13. Fox JE. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinol. 1994;5:291–304.

    Google Scholar 

  14. Serebruany VL, Gurbel PA. Assessment of platelet activity by measuring platelet derived substances in plasma from patients with acute myocardial infarction: Surprising lessons from the GUSTO-III platelet study. Thromb Res. 1999;93:149–150.

    Article  PubMed  Google Scholar 

  15. Lip GYH, Lydakis C, Nuttall SL et al. A pilot study of streptokinase-induced endothelial injury and platelet activation following myocardial infaction. J Int Med. 2000;248:316–318.

    Article  Google Scholar 

  16. Mascelli MA, Worley S, Veriabo NJ, et al. Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy. Circulation. 1997;96:3860–3866.

    PubMed  Google Scholar 

  17. Peerschke EIB, Reid KBM, Ghebrehiwet B. Platelet activation by C1q results in the induction of alphaIIb/beta3 integrins (GPIIb/IIIa) and the expression of P.-Selectin and procoagulant activity. J Exp Med. 1993;178:579–587.

    Article  PubMed  Google Scholar 

  18. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420–1426.

    Article  PubMed  Google Scholar 

  19. May AE, Neumann FJ, Gawaz M, Ott I, Walter H, Schömig A. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur Heart J. 1997;18:1913–1920.

    PubMed  Google Scholar 

  20. Fan ST, Edgington TS. Coupling of the adhesive receptor CD 11b/18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 1991;87:50–57.

    PubMed  Google Scholar 

  21. Altieri DC, Morrissey JH, Edgington TS. Adehesive receptor MAC-1 coordinates the activation of factor X on stimulated cells of monocyte and myeloid differentiation: An alternative initiation of the coagulation protease cascades. Proc Natl Acad Sci USA. 1988;85:7462.

    PubMed  Google Scholar 

  22. Meisel SR, Shapiro H, Radnay J, et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: Possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol. 1998;31:120–125.

    Article  PubMed  Google Scholar 

  23. Furie B, Furie BC. Leukocyte crosstalk at the vascular wall. Thromb Haemost. 1997;78:306–309.

    PubMed  Google Scholar 

  24. Lopez JA, Dong JF, Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol. 1997;4:323–329.

    PubMed  Google Scholar 

  25. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogenity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. Am Heart J. 1998;136:398–405.

    PubMed  Google Scholar 

  26. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on glycoprotein Ib-von Willebrand factor interactions. Blood. 1985;65:32–40.

    PubMed  Google Scholar 

  27. Szabo S, Etzel D, Ehlers R, et al. Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis. Drugs Exptl Clin Res. 2004;XXX:47–54.

    Google Scholar 

  28. Mach F, Schonbeck U, Sukhova GK et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signalling in atherosclerosis. Proc Natl Acad Sci USA. 1997;94:1931–1936.

    Article  PubMed  Google Scholar 

  29. Heeschen C, Dimmeler S, Hamm CW; CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104–1111.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, Städtisches Klinikum, Solingen, Germany

    Sebastian Szabo MD, Silke Kazmaier, Uwe Helber & Hans Martin Hoffmeister

  2. Department of Internal Medicine III, University of Tuebingen, Tübingen, Germany

    Diana Etzel, Raila Ehlers & Thomas Walter

  3. Klinik für Kardiologie und Allgemeine Innere Medizin, Städtisches Klinikum Solingen, Gotenstr. 1, 42653, Solingen, Germany

    Sebastian Szabo MD

Authors
  1. Sebastian Szabo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diana Etzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raila Ehlers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silke Kazmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Uwe Helber
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hans Martin Hoffmeister
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Szabo MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szabo, S., Etzel, D., Ehlers, R. et al. Combined Thrombolysis with Abciximab Favourably Influences Platelet-Leukocyte Interactions and Platelet Activation in Acute Myocardial Infarction. J Thromb Thrombolysis 20, 155–161 (2005). https://doi.org/10.1007/s11239-005-3546-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-005-3546-0

Key Words

Search

Navigation